Actively Recruiting
Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia
Led by University Hospital, Toulouse · Updated on 2024-08-02
128
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate the use of automated oxygen therapy in patients hospitalized with hypoxemic pneumonia, a condition that often requires oxygen support and leads to prolonged hospital stays. The study compares automated oxygen delivery with standard oxygen therapy to see if it can reduce the length of hospitalization. Pneumonia can cause serious complications and increases healthcare costs, so finding effective oxygen management is important for patient recovery and resource use. Participants are divided into two groups: one receiving oxygen through an automated system called FreeO2, which continuously adjusts oxygen flow based on the patient's saturation levels, set by clinicians; and the other group receiving standard oxygen therapy via nasal goggles or masks, with flow adjusted periodically following hospital protocols. Oxygen saturation is closely monitored in both groups. The study lasts one month and includes ongoing assessment of oxygen use and patient experience. Throughout the study, patients will be closely monitored for length of hospital stay, duration of oxygen therapy, time spent outside target oxygen saturation, medical complications, and economic costs. Quality of life during hospitalization will also be evaluated through questionnaires. Researchers will collect detailed data for one month, allowing them to compare outcomes between automated and standard oxygen therapies and assess potential benefits. The study is randomized and open-label, with no masking.
CONDITIONS
Brief Title
Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult aged 18 years or older
- Patient living at home or in an institution
- Hospitalized for less than 48 hours
- Pneumonia diagnosis with respiratory symptoms (cough, sputum, difficulty breathing, chest pain)
- Fever above 38.5°C or low body temperature below 36°C
- Radiological signs of pneumonia
- Low oxygen levels (SpO2 below 94% in room air or PaO2 below 60 mmHg in room air)
You will not qualify if you...
- Pneumonia acquired in the hospital
- Hospitalized in another department for more than 48 hours before admission
- Chronic respiratory failure
- Active cancer (neoplasia)
- Currently on oxygen therapy or long-term non-invasive ventilation
- Heart failure with clinical signs or high NTproBNP levels above 1800 ng/mL
- Need for high flow oxygen therapy or ventilatory support at the start
- Expected difficulties with home support after discharge
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 1 month during hospitalization
Participants receive either automated oxygen therapy with a device that continuously adjusts oxygen flow based on saturation, or standard oxygen therapy using nasal goggles or a mask, according to local protocols.
Oxygen therapy administered continuously during hospital stay
Trial Site Locations
Total: 1 location
1
CHU Larrey
Toulouse, France, 31049
Actively Recruiting
Research Team
E
Elise Noel-Savina, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here